← Back

Wire · opportunities

FDA Approves OTC 12-Hour Cold and Fever Medication

Published

8 August 2026

Topic

opportunities

Sectors

Health

Geography

United States

Source

Read at respiratory-therapy.com

Verified

Fusion42 · 28 August 2026 · Fusion42 review

The FDA approved Mucinex 12hr Cold & Fever Multi-Symptom, the first OTC cold and flu medication innovation in 14 years, featuring a triple-action formula providing up to 12 hours of relief. This approval follows over a decade of clinical research aimed at extending symptom management for cold and flu sufferers in the US.

This Wire brief sits within Fusion42's coverage of Health.

◆ The Wire takeaway

You need to rethink your cold and flu product timelines as US regulatory barriers around OTC innovation just eased. This approval opens new opportunities for longer-lasting symptom relief formulations to compete in a US market starved for fresh options.

Coverage

1 source · 8 Aug 2026

Related on Wire

Topics

Healthfda-approvalotc-medicationcold-flulong-lasting-reliefmucinexreckitt